News & Analysis on Clinical Trial Services & Contract Research And Development
A clinic dedicated to providing care and services to undeserved and uninsured individuals with Duchenne and Becker muscular dystrophy opened its doors on Friday (March 3).
A licensing agreement has been signed that will give Spanish pharma company, Ferrer, worldwide rights to a treatment for progressive supranuclear palsy (PSP).
SCOPE 2023
Year on year, the SCOPE summit brings thousands of people working in the pharma field together and the last one attracted more than 2,300 leaders in clinical operations and research.
Novo Nordisk is to expand its research and development (R&D) presence in the greater Boston metro area.